Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Blood Donors"" wg kryterium: Temat


Tytuł :
Analysis of blood donors' characteristics and deferrals related to COVID-19 in Iran.
Autorzy :
Rafiee MH; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, 14665-1157, Iran.
Kafiabad SA; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, 14665-1157, Iran. Electronic address: .
Maghsudlu M; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, 14665-1157, Iran.
Pokaż więcej
Źródło :
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2021 Apr; Vol. 60 (2), pp. 103049. Date of Electronic Publication: 2021 Jan 02.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
COVID-19*/blood
COVID-19*/epidemiology
COVID-19 Testing*
Databases, Factual*
Disease Outbreaks*
Donor Selection*
SARS-CoV-2*
Adolescent ; Adult ; Female ; Humans ; Iran/epidemiology ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Assessment of blood supply and usage pre- and during COVID-19 pandemic: A lesson from non-voluntary donation.
Autorzy :
Ogar CO; Hematology Unit, Department of Medical Laboratory Science, University of Calabar, Nigeria.
Okoroiwu HU; Hematology Unit, Department of Medical Laboratory Science, University of Calabar, Nigeria. Electronic address: .
Obeagu EI; Department of Medical Laboratory Science, Imo State University, Nigeria.
Etura JE; Hematology Unit, Department of Medical Laboratory Science, University of Calabar, Nigeria.
Abunimye DA; Hematology Unit, Department of Medical Laboratory Science, University of Calabar, Nigeria.
Pokaż więcej
Źródło :
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine [Transfus Clin Biol] 2021 Feb; Vol. 28 (1), pp. 68-72. Date of Electronic Publication: 2020 Oct 17.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Pandemics*
SARS-CoV-2*
Blood Donors/*statistics & numerical data
Blood Transfusion/*statistics & numerical data
Adolescent ; Adult ; Blood Donors/psychology ; Blood Donors/supply & distribution ; Blood Transfusion/economics ; Blood Transfusion/psychology ; Cross-Sectional Studies ; Family ; Female ; Hospitals, Teaching/statistics & numerical data ; Hospitals, Urban/statistics & numerical data ; Humans ; Male ; Middle Aged ; Motivation ; Nigeria ; Occupations ; Procedures and Techniques Utilization ; Remuneration ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Lateral ST-elevation myocardial infarction after donation of COVID-19 convalescent plasma in a naïve donor.
Autorzy :
Shams P; Adult Cardiology, Aga Khan University, Karachi, Pakistan .
Tipoo FA; Adult Cardiology, Aga Khan University, Karachi, Pakistan.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Mar 24; Vol. 14 (3). Date of Electronic Publication: 2021 Mar 24.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Blood Donors*
COVID-19/*therapy
Coronary Thrombosis/*complications
ST Elevation Myocardial Infarction/*etiology
Adult ; COVID-19/blood ; Coronary Angiography/methods ; Coronary Thrombosis/diagnosis ; Coronary Thrombosis/therapy ; Electrocardiography/methods ; Humans ; Immunization, Passive/adverse effects ; Male ; Percutaneous Coronary Intervention/methods ; Plasma ; SARS-CoV-2 ; ST Elevation Myocardial Infarction/diagnosis ; ST Elevation Myocardial Infarction/therapy ; Thrombectomy/methods ; Treatment Outcome
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy.
Autorzy :
Gontu A; Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, USA.
Srinivasan S; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.
Salazar E; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA.
Nair MS; Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, USA.
Nissly RH; Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, USA.
Greenawalt D; Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, USA.
Bird IM; Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, USA.
Herzog CM; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.
Ferrari MJ; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.; Department of Biology, Pennsylvania State University, University Park, PA, USA.
Poojary I; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.
Katani R; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.
Lindner SE; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.; Department of Biochemistry, Microbiology, and Molecular Biology, Pennsylvania State University, University Park, PA, USA.
Minns AM; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.; Department of Biochemistry, Microbiology, and Molecular Biology, Pennsylvania State University, University Park, PA, USA.
Rossi R; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.
Christensen PA; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA.
Castillo B; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA.
Chen J; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA.
Eagar TN; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
Yi X; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
Zhao P; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA.
Leveque C; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA.
Olsen RJ; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.; Center for Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute, Houston, TX, USA.
Bernard DW; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA.; Center for Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute, Houston, TX, USA.
Gollihar J; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA.; CCDC Army Research Laboratory-South, Austin, TX, USA.
Kuchipudi SV; Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA, USA. .; Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA, USA. .
Musser JM; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA. .; Department of Biochemistry, Microbiology, and Molecular Biology, Pennsylvania State University, University Park, PA, USA. .; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA. .
Kapur V; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA. .; Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA, USA. .; Department of Animal Science, Pennsylvania State University, University Park, PA, USA. .
Pokaż więcej
Źródło :
Communications biology [Commun Biol] 2021 Feb 24; Vol. 4 (1), pp. 267. Date of Electronic Publication: 2021 Feb 24.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
COVID-19/*immunology
SARS-CoV-2/*immunology
Adult ; Age Factors ; Aged ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; COVID-19/blood ; COVID-19/therapy ; Female ; Humans ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Immunoglobulin M/blood ; Immunoglobulin M/immunology ; Longitudinal Studies ; Male ; Middle Aged ; Severity of Illness Index ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Comment on "Delayed adverse events in male plateletpheresis donors: Initial insights on donor safety".
Autorzy :
Mukherjee S; Department of Transfusion Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
Prakash S; Department of Transfusion Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
Pokaż więcej
Źródło :
Journal of clinical apheresis [J Clin Apher] 2021 Feb; Vol. 36 (1), pp. 221-222. Date of Electronic Publication: 2020 Sep 24.
Typ publikacji :
Letter; Comment
MeSH Terms :
Blood Donors*
Plateletpheresis*
Humans ; Male
Opinia redakcyjna
Tytuł :
The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region.
Autorzy :
Al-Riyami AZ; Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman. Electronic address: .
Abdella YE; Regional office for the Eastern Mediterranean, World Health Organization, Cairo, Egypt. Electronic address: .
Badawi MA; King Abdulaziz University, Jeddah, Saudi Arabia; King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Electronic address: .
Panchatcharam SM; Oman Medical Specialty Board, Muscat, Oman. Electronic address: .
Ghaleb Y; National Blood Transfusion and Research Center, Sana'a, Yemen. Electronic address: .
Maghsudlu M; Blood Transfusion Research Center, High Institution for Research and Education in Transfusion Medicine, Tehran, Iran. Electronic address: .
Satti M; Department of Pathology, Faculty of Medicine, University of Khartoum, Khartoum, Sudan. Electronic address: .
Lahjouji K; National Blood Transfusion and Hematology, Rabat, Morocco. Electronic address: .
Merenkov Z; Transfusion Medicine and Laboratory Information Systems, Hamad Medical Corporation, Doha, Qatar. Electronic address: .
Adwan A; Ministry of health, Amman, Jordan. Electronic address: .
Feghali R; Department of Laboratory Medicine, Rafik-Hariri University Hospital, Beirut, Lebanon. Electronic address: .
Gebril N; National Blood Services, Tripoli, Libya. Electronic address: .
Hejress S; Blood Bank and Laboratory Medicine, Department of Pathology, King Hamad University Hospital & Bahrain Oncology Centre, Al-Sayh, Bahrain. Electronic address: .
Hmida S; National Blood Transfusion Centre of Tunis, Tunis, Tunisia. Electronic address: .
AlHumaidan H; Department of Pathology & Laboratory Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. Electronic address: .
Jamal D; Sindh Blood Transfusion Authority, Karachi, Pakistan. Electronic address: .
Najjar O; Palestinian Ministry of Health, Ramallah, Palestine. Electronic address: .
Raouf M; Dubai Blood Donation Centre, Dubai Health Authority, Dubai, United Arab Emirates. Electronic address: .
Pokaż więcej
Źródło :
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine [Transfus Clin Biol] 2021 Feb; Vol. 28 (1), pp. 16-24. Date of Electronic Publication: 2020 Dec 01.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/prevention & control
Pandemics*
SARS-CoV-2*
Blood Banks/*statistics & numerical data
Blood Donors/*supply & distribution
Blood Transfusion/*statistics & numerical data
Africa, Northern ; Blood Banks/organization & administration ; Blood Donors/psychology ; Donor Selection/standards ; Health Care Surveys ; Hematologic Neoplasms/therapy ; Hemoglobinopathies/therapy ; Humans ; Infection Control/organization & administration ; Infectious Disease Transmission, Patient-to-Professional/prevention & control ; Infectious Disease Transmission, Professional-to-Patient/prevention & control ; Mediterranean Region ; Middle East ; Pakistan ; Professional-Patient Relations
Czasopismo naukowe
Tytuł :
COVID-19: Further evidence of no transfusion transmission.
Autorzy :
Luzzi JR; Unidade de Hemoterapia e Hematologia Samaritano, São Paulo, Brazil.
Navarro R; Unidade de Hemoterapia e Hematologia Samaritano, São Paulo, Brazil.
Dinardo CL; Unidade de Hemoterapia e Hematologia Samaritano, São Paulo, Brazil. Electronic address: .
Pokaż więcej
Źródło :
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2021 Feb; Vol. 60 (1), pp. 102961. Date of Electronic Publication: 2020 Oct 07.
Typ publikacji :
Letter
MeSH Terms :
Blood Donors*
Blood Transfusion*
COVID-19*/blood
COVID-19*/transmission
SARS-CoV-2/*metabolism
Blood-Borne Infections/blood ; Blood-Borne Infections/transmission ; Female ; Humans ; Male
Opinia redakcyjna
Tytuł :
What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
Autorzy :
Focosi D; North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy. Electronic address: .
Tuccori M; Division of Pharmacovigilance, Pisa University Hospital, Pisa, Italy.
Antonelli G; Laboratory of 'Microbiology and Virology', Department of Molecular Medicine, University Hospital 'Policlinico Umberto I' Sapienza University, Rome, Italy.
Maggi F; Division of Virology, University of Pisa, Pisa, Italy.
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Feb; Vol. 27 (2), pp. 163-165. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Plasma*
COVID-19/*therapy
COVID-19/economics ; Clinical Trials as Topic ; Humans ; Immunization, Passive/economics ; Immunization, Passive/standards
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates.
Autorzy :
Boonyaratanakornkit J; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Seattle Cancer Care Alliance, Seattle, Washington, USA.
Morishima C; Department of Laboratory Medicine and Pathology, and.
Selke S; Department of Laboratory Medicine and Pathology, and.
Zamora D; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
McGuffin S; Department of Medicine, University of Washington, Seattle, Washington, USA.
Shapiro AE; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.
Campbell VL; Department of Medicine, University of Washington, Seattle, Washington, USA.
McClurkan CL; Department of Medicine, University of Washington, Seattle, Washington, USA.
Jing L; Department of Medicine, University of Washington, Seattle, Washington, USA.
Gross R; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Frederick, Maryland, USA.
Liang J; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Frederick, Maryland, USA.
Postnikova E; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Frederick, Maryland, USA.
Mazur S; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Frederick, Maryland, USA.
Lukin VV; Kearney, Chicago, Illinois, USA.
Chaudhary A; Department of Laboratory Medicine and Pathology, and.
Das MK; Department of Laboratory Medicine and Pathology, and.
Fink SL; Department of Laboratory Medicine and Pathology, and.
Bryan A; Department of Laboratory Medicine and Pathology, and.
Greninger AL; Department of Laboratory Medicine and Pathology, and.
Jerome KR; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, and.
Holbrook MR; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Frederick, Maryland, USA.
Gernsheimer TB; Department of Medicine, University of Washington, Seattle, Washington, USA.; Seattle Cancer Care Alliance, Seattle, Washington, USA.
Wener MH; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, and.
Wald A; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Koelle DM; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, and.; Department of Global Health, University of Washington, Seattle, Washington, USA.; Benaroya Research Institute, Seattle, Washington, USA.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2021 Feb 01; Vol. 131 (3).
Typ publikacji :
Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Antibodies, Neutralizing*/blood
Antibodies, Neutralizing*/immunology
Antibodies, Viral*/blood
Antibodies, Viral*/immunology
Blood Donors*
Immunoglobulin G*/blood
Immunoglobulin G*/immunology
SARS-CoV-2*/immunology
SARS-CoV-2*/metabolism
COVID-19/*therapy
Adult ; Aged ; Aged, 80 and over ; COVID-19/blood ; COVID-19/immunology ; Female ; Humans ; Immunization, Passive ; Male ; Middle Aged
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Post-donation information and haemovigilance reporting for COVID-19 in Greece: Information supporting the absence of SARS-CoV-2 possible transmission through blood components.
Autorzy :
Politis C; Coordinating Centre for Haemovigilance and Surveillance of Transfusion, Hellenic National Public Health Organization,, Athens, Greece. Electronic address: .
Papadaki M; Blood transfusion service, Sotiria thoracic diseases hospital of Athens, Athens, Greece.
Politi L; Laboratory of microbiology, medical school, National and Kapodistrian University of Athens, Athens, Greece.
Kourti G; Haematology department, Sotiria thoracic diseases hospital of Athens, Athens, Greece.
Richardson C; Panteion university of social and political sciences, Athens, Greece.
Asariotou M; Coordinating Centre for Haemovigilance and Surveillance of Transfusion, Hellenic National Public Health Organization,, Athens, Greece.
Tsakris A; Laboratory of microbiology, medical school, National and Kapodistrian University of Athens, Athens, Greece.
Mentis A; Public health laboratories, Hellenic Pasteur Institute, Athens, Greece.
Pokaż więcej
Źródło :
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine [Transfus Clin Biol] 2021 Feb; Vol. 28 (1), pp. 55-59. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Blood Donors*
Blood Safety*
Pandemics*
Blood Component Transfusion/*adverse effects
COVID-19/*transmission
Donor Selection/*standards
SARS-CoV-2/*isolation & purification
Viremia/*transmission
Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Asymptomatic Infections ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/prevention & control ; COVID-19 Testing ; Contact Tracing ; Female ; Greece/epidemiology ; Humans ; Immunocompromised Host ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/therapy ; Male ; Middle Aged ; Platelet-Rich Plasma ; Police ; Viremia/blood ; Viremia/diagnosis
Czasopismo naukowe
Tytuł :
The effect of the COVID-19 pandemic on the adequacy of blood supply: Specialists in transfusion medicine need to establish models of preparedness.
Autorzy :
Rouka E; Department of Transfusion Medicine, University Hospital of Larissa, Thessalia, Greece. Electronic address: .
Pokaż więcej
Źródło :
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2021 Feb; Vol. 60 (1), pp. 102960. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji :
Letter
MeSH Terms :
Blood Banks*
Blood Donors*
Blood Safety*
Pandemics*
SARS-CoV-2*
COVID-19/*epidemiology
Humans ; Transfusion Medicine
Opinia redakcyjna
Tytuł :
Blood Donation and COVID-19: Reconsidering the 3-Month Deferral Policy for Gay, Bisexual, Transgender, and Other Men Who Have Sex With Men.
Autorzy :
Park, Christopher ()
Gellman, Caroline ()
O'Brien, Madeline ()
Eidelberg, Andrew ()
Subudhi, Ipsita ()
Gorodetsky, Elizabeth F. ()
Asriel, Benjamin ()
Furlow, Andrew ()
Mullen, Michael ()
Nadkarni, Girish ()
Somani, Sulaiman ()
Sigel, Keith ()
Reich, David L. ()
Pokaż więcej
Temat :
COVID-19
GAY men as blood donors
MEDICAL policy
BLOOD donors
PATIENT safety
PSYCHOLOGY of LGBTQ+ people
Źródło :
American Journal of Public Health. Feb2021, Vol. 111 Issue 2, p247-252. 6p.
Czasopismo naukowe
Tytuł :
Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries.
Autorzy :
Bloch EM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Goel R; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Division of Hematology/Oncology, Simmons Cancer Institute at SIU School of Medicine and Mississippi Valley Regional Blood Center, Springfield, Illinois, USA.
Wendel S; Hospital Sirio Libanês, São Paulo, Brazil.
Burnouf T; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.; International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.
Al-Riyami AZ; Department of Hematology, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman.
Ang AL; Blood Services Group, Health Sciences Authority, Singapore, Singapore.
DeAngelis V; Transfusion Medicine Dept, Udine University Hospital, Udine, Italy.
Dumont LJ; Vitalant Research Institute, Denver, CO, USA.; University of Colorado School of Medicine, Denver, CO, USA.; Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Land K; Vice President Clinical Services, Vitalant, Scottsdale, AZ, USA.; Department of Pathology, UT Health Science Center San Antonio, San Antonio, TX, USA.
Lee CK; Hong Kong Red Cross Blood Transfusion Service, Hong Kong, China, China.; King's Park Rise, Kowloon, China.
Oreh A; National Blood Transfusion Service, Department of Hospital Services, Federal Ministry of Health, Abuja, Nigeria.
Patidar G; Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India.
Spitalnik SL; Department of Pathology & Cell Biology, Columbia University, New York, NY, USA.
Vermeulen M; The South African National Blood Service, Johannesbur, South Africa.
Hindawi S; Haematology & Transfusion Medicine, King Abdalaziz University, Jeddah, Saudi Arabia.
Van den Berg K; The South African National Blood Service, Johannesbur, South Africa.
Tiberghien P; Etablissement Français du Sang, Paris, France.
Vrielink H; Department Unit Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam, NL, Netherlands.
Young P; American Red Cross, Washington, D.C, USA.
Devine D; Canadian Blood Services, Vancouver, BC, Canada.; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
So-Osman C; Department Unit Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam, NL, Netherlands.; Department of Haematology, Erasmus Medical Center, Rotterdam, NL, Netherlands.
Pokaż więcej
Źródło :
Vox sanguinis [Vox Sang] 2021 Jan; Vol. 116 (1), pp. 18-35. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
COVID-19/*therapy
Developing Countries ; Guidelines as Topic ; Health Care Surveys ; Humans ; Immunization, Passive ; SARS-CoV-2
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Iron deficiency among French whole-blood donors: first assessment and identification of predictive factors.
Autorzy :
Fillet AM; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Martinaud C; Centre de Transfusion Sanguine des Armées, Clamart, France.
Malard L; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Le Cam S; Etablissent Français du sang, Blood Biological Qualification, Angers, France.
Hejl C; Laboratory Medicine Department, Military Medical Center Percy, Clamart, France.
Chenus F; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Woimant G; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Chueca M; Centre de Transfusion Sanguine des Armées, Clamart, France.
Jacquot E; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Besiers C; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Morel P; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Djoudi R; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Garrabé E; Centre de Transfusion Sanguine des Armées, Clamart, France.
Gross S; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Pokaż więcej
Źródło :
Vox sanguinis [Vox Sang] 2021 Jan; Vol. 116 (1), pp. 42-52. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Blood Donors*
Ferritins/*blood
Hemoglobins/*analysis
Iron/*deficiency
Female ; France ; Humans ; Male ; Middle Aged ; Prevalence ; Prospective Studies
Czasopismo naukowe
Tytuł :
Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan.
Autorzy :
Younas A; Clinical Haematology Departments at National Institute of Blood Diseases & Bone Marrow Transplantation, Karachi, Pakistan.
Waheed S; Blood Bank, Karachi, Pakistan; Pathology Department, Karachi, Pakistan. Electronic address: .
Khawaja S; Pathology Department, Karachi, Pakistan.
Imam M; Transplant Immunology, Karachi, Pakistan.
Borhany M; Blood Bank, Karachi, Pakistan; Clinical Haematology Departments at National Institute of Blood Diseases & Bone Marrow Transplantation, Karachi, Pakistan.
Shamsi T; Clinical Haematology Departments at National Institute of Blood Diseases & Bone Marrow Transplantation, Karachi, Pakistan.
Pokaż więcej
Źródło :
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2020 Dec; Vol. 59 (6), pp. 102923. Date of Electronic Publication: 2020 Aug 24.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Donor Selection*
Antibodies, Viral/*blood
COVID-19/*blood
SARS-CoV-2/*metabolism
Adult ; Female ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Male ; Pakistan ; Seroepidemiologic Studies
Czasopismo naukowe
Tytuł :
Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses.
Autorzy :
Schlickeiser S; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Schwarz T; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Institute of Virology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, and German Centre for Infection Research (DZIF), Partner Site Charité, Berlin, Germany.
Steiner S; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Wittke K; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Al Besher N; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Meyer O; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Kalus U; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Pruß A; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Kurth F; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Zoller T; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Witzenrath M; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Center for Lung Research (DZL), Partner Site Charité, Berlin, Germany.
Sander LE; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Center for Lung Research (DZL), Partner Site Charité, Berlin, Germany.
Müller MA; Institute of Virology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, and German Centre for Infection Research (DZIF), Partner Site Charité, Berlin, Germany.
Scheibenbogen C; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Volk HD; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Drosten C; Institute of Virology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, and German Centre for Infection Research (DZIF), Partner Site Charité, Berlin, Germany.
Corman VM; Institute of Virology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, and German Centre for Infection Research (DZIF), Partner Site Charité, Berlin, Germany.
Hanitsch LG; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Jan 29; Vol. 11, pp. 628971. Date of Electronic Publication: 2021 Jan 29 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
COVID-19/*immunology
COVID-19/*therapy
Adolescent ; Adult ; Age Factors ; Aged ; Convalescence ; Female ; Fever ; Humans ; Immunization, Passive ; Male ; Middle Aged ; SARS-CoV-2/immunology ; Severity of Illness Index ; Sex Factors ; Young Adult
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.
Autorzy :
Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine Aarhus University, Aarhus, Denmark.
Hother CE; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Pedersen OBV; Department of Clinical Immunology, Zealand University Hospital, Naestved, Denmark.
Mølbak K; Infection Control, Statens Serum Institut, Copenhagen, Denmark.
Skov RL; Infection Control, Statens Serum Institut, Copenhagen, Denmark.
Holm DK; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Sækmose SG; Department of Clinical Immunology, Zealand University Hospital, Naestved, Denmark.
Nilsson AC; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Brooks PT; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Boldsen JK; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine Aarhus University, Aarhus, Denmark.
Mikkelsen C; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Gybel-Brask M; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Sørensen E; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Dinh KM; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine Aarhus University, Aarhus, Denmark.
Mikkelsen S; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine Aarhus University, Aarhus, Denmark.
Møller BK; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine Aarhus University, Aarhus, Denmark.
Haunstrup T; Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
Harritshøj L; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Jensen BA; Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
Hjalgrim H; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Lillevang ST; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Ullum H; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jan 27; Vol. 72 (2), pp. 249-253.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
COVID-19*
Adolescent ; Adult ; Aged ; Antibodies, Viral ; Humans ; Middle Aged ; SARS-CoV-2 ; Seroepidemiologic Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Epidemiological survey and screening strategy for dengue virus in blood donors from Yunnan Province.
Autorzy :
Li L; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.
Li Y; Xishuangbanna Blood Center, Xishuangbanna, China.
Lu S; Xishuangbanna Blood Center, Xishuangbanna, China.
Dong J; Xishuangbanna Blood Center, Xishuangbanna, China.
Xu H; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.
Zhang Q; Xishuangbanna Blood Center, Xishuangbanna, China.
Weng R; Xishuangbanna Blood Center, Xishuangbanna, China.
Yin Y; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.
He R; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.
Fang P; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Anhui Medical University, Hefei, China.
Shi H; Xishuangbanna Blood Center, Xishuangbanna, China.
Yu Y; Xishuangbanna Blood Center, Xishuangbanna, China.
Wu J; Xishuangbanna Blood Center, Xishuangbanna, China. .
Liu Z; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China. .; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China. .
Hess JR; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, USA.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Jan 22; Vol. 21 (1), pp. 104. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Dengue/*diagnosis
Dengue/*epidemiology
Dengue Virus/*isolation & purification
Mass Screening/*methods
Adult ; Antibodies, Viral/blood ; China/epidemiology ; Dengue/blood ; Dengue Virus/genetics ; Dengue Virus/immunology ; Female ; Humans ; Male ; Mass Screening/statistics & numerical data ; Middle Aged ; Prevalence ; RNA, Viral/genetics ; Viral Nonstructural Proteins/genetics ; Young Adult
Czasopismo naukowe
Tytuł :
Molecular characteristics of HBV infection among blood donors tested HBsAg reactive in a single ELISA test in southern China.
Autorzy :
Ye X; Shenzhen Blood Center, Meigang South Road, Shenzhen, 518000, P. R. China.
Li T; Shenzhen Blood Center, Meigang South Road, Shenzhen, 518000, P. R. China.
Li R; Shenzhen Blood Center, Meigang South Road, Shenzhen, 518000, P. R. China.
Liu H; Shenzhen Blood Center, Meigang South Road, Shenzhen, 518000, P. R. China.
Zhao J; Shenzhen Blood Center, Meigang South Road, Shenzhen, 518000, P. R. China. .; Department of Transfusion, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Jiefang Load 88, Hangzhou, 310000, P. R. China. .
Zeng J; Shenzhen Blood Center, Meigang South Road, Shenzhen, 518000, P. R. China. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Jan 19; Vol. 21 (1), pp. 83. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Hepatitis B*
Hepatitis B Surface Antigens/*blood
Hepatitis B virus/*genetics
China ; DNA, Viral/genetics ; Enzyme-Linked Immunosorbent Assay ; Humans ; Nucleic Acid Amplification Techniques ; Phylogeny ; Polymerase Chain Reaction/methods
Czasopismo naukowe
Tytuł :
Syncopal-type reactions tend to be delayed and result in falls among elderly blood donors.
Autorzy :
Namba N; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Ishimaru F; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Kondo G; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Hashizume T; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Kunii N; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Shibata R; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Sawamura Y; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Kato T; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Pokaż więcej
Źródło :
Vox sanguinis [Vox Sang] 2021 Jan; Vol. 116 (1), pp. 36-41. Date of Electronic Publication: 2020 Jul 23.
Typ publikacji :
Journal Article
MeSH Terms :
Accidental Falls*
Blood Donors*
Syncope*
Adolescent ; Adult ; Age Factors ; Aged ; Female ; Humans ; Japan ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Sex Factors ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies